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Purpose: To report the surgical management of a combined rhegmatogenous and traction retinal
detachment associated with a vasoproliferative tumor secondary to sickle cell retinopathy.
Observations: A 29 year old man from Ghana presented with unilateral vision loss, ischemic retina and
sea fan neovascularization in both eyes and a retinal detachment nearby a vasoproliferative tumor (VPT)
in the left eye. Hemoglobin electrophoresis led to the diagnosis of sickle cell disease. The patient un-
derwent vitrectomy with scleral buckle surgery, resection of the tumor, and removal of subretinal
membranes in the left eye. Laser photocoagulation was targeted to areas of ischemic retina in both eyes.
Conclusions: and Importance: To our knowledge, this is the ﬁrst report of a combined rhegmatogenous
and traction retinal detachment associated with a VPT in sickle cell retinopathy managed by modern
vitrectomy techniques. Prompt recognition of the condition and surgical management addressing both
rhegmatogenous and tractional components can lead to improved outcome.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1.. Introduction
Vasoproliferative tumors are described as benign masses of
neovascularization.1 Approximately 75% of reported cases are
idiopathic or primary VPT occurring mostly in healthy patients.2
Secondary VPT have been associated with uveitis,3 retinitis pig-
mentosa, chronic retinal detachment, Coats’ disease, prior retinal
detachment repair, idiopathic peripheral retinal vasculitis, familial
exudative vitreoretinopathy, toxoplasmosis, aniridia, congenital
hypertrophy of retinal pigment epithelium, idiopathic choroiditis,
retinopathy of prematurity, and histoplasmosis.2 We report the
management of a VPT associated with a traction and rhegmatoge-
nous retinal detachment secondary to sickle cell retinopathy (SCR).2. Case report
A 29-year-old man from Ghana presented with loss of vision in
the left eye for several months. Vision was 20/20 in the right eye
and count ﬁngers in the left eye. Retinal exam showed ischemic
retina and multiple areas of ﬁbrovascular proliferation in each eye, Austin, TX 78705, USA.
ong).
Inc. This is an open access article u(Fig. 1). Additionally, a vascularized mass with dilated feeder ves-
sels was found in the temporal periphery along with a combined
tractional (TRD) and rhegmatogenous retinal detachment (RRD)
with a small retinal hole in the left eye. Wideﬁeld ﬂuorescein
angiography (FA) (Fig. 2) revealed sea-fan neovascularization in the
peripheral retina. Ultrasound measurements of
3.6 mm  16.2 mm  18.2 mm and high internal reﬂectivity
through the lesion were suggestive of a vascular tumor (Fig. 3).
Hemoglobin electrophoresis revealed the presence of sickle cell
(SC) trait leading to the diagnosis of SCR.
Due to the retinal detachment, pre-operative anti-VEGF therapy,
laser or cryotherapywas deferred. The patient underwent 23-g pars
plana vitrectomywith placement of a scleral buckle encircling band
to support the vitreous base. Triamcinolone aided identiﬁcation
and removal of the posterior hyaloid. Intra-operatively, the mass
was found to cause considerable foreshortening of the retina and
reattachment could not be performed without resecting the tumor.
Diathermy was used to cauterize the feeder vessels and then to
circumscribe the lesion prior to resection of the tumor. Unfortu-
nately, the resected lesion was unable to be adequately recovered
by the pathologist for further tissue identiﬁcation and histopa-
thology. Nearby subretinal membranes were resected through the
newly created localized retinectomy. Laser photocoagulation was
then applied to the retinectomy as well as areas of ischemic retina.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Color Fundus Photography. (A) Right eye showing infarcted sea-fan neovascularization in the temporal periphery as well as ischemic retina and ghost vessels. A black
sunburst is seen in the superonasal retina. (B) Left eye showing dilated vessels and vascularized mass in temporal periphery. Subretinal ﬁbrosis and an atrophic hole (yellow arrow)
has led to a combined tractional-rhegmatogenous retinal detachment. Subretinal ﬂuid is seen within the macula and beneath the fovea. (C) Right eye 1 week following laser
photocoagulation to ischemic retina. (D) Left eye 1 week following vitrectomy, resection of vasoproliferative tumor and removal of subretinal membrane. Laser photocoagulation is
applied to the ischemic retina as well as the retinectomy and along the scleral buckle. Silicone tamponade was placed over an attached retina. (For interpretation of the references to
color in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 2. Wide-ﬁeld ﬂuorescein angiography. (A) Mid-phase angiogram of the right eye showing capillary non-perfusion in the mid-to far periphery. Neovascularization of the retina
as well as a black sunburst lesion (superonasal) are seen. (B) Early-phase angiogram of the left eye showing dilated and tortuous vasculature leading up to a highly vascularized mass
lesion. Widespread capillary non-perfusion and neovascularization is also seen.
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with laser photocoagulation to the areas capillary non-perfusion.
Post-operatively, the patient developed cataract in the left eye
which was later replaced with a posterior chamber intraocular lens.
Four months after silicone oil removal, his retina remained
attached and his vision improved to 20/400.
The patient provided written consent for publication of personal
information including medical record details and photographs.
3. Discussion
Sickle cell disease results from a single point genetic mutation
that results in a structural change to the hemoglobin polypeptide
chains which disrupts erythrocyte architecture, promoting cellular
dehydration and resulting in the sickled appearance of red bloodcells.4 The sickled erythrocytes can result in ischemia and infarction
of local tissues.5 Sickle cell retinopathy (SCR) is found more
commonly in the SC and S-b thalassemia subtypes of compound
heterozygotes which can be differentiated through hemoglobin
electrophoresis.6,7 In patients with SCR, occlusion of the retinal
vasculature can lead to areas of profound capillary non-perfusion
where neovascular lesions can develop and progressively increase
in number and size often developing into shapes of sea fans.6
Though spontaneous regression, or autoinfarction, of the retinal
neovascularization can occur, sickle cell retinopathy is strongly
associated with vision loss in as many as 10% of affected patients
primarily through the development of vitreous hemorrhage or
retinal detachment.6
Retinal neovascularization has been associated with retinal
vascular diseases including diabetic retinopathy, retinal vein
Fig. 3. A and B Scan ultrasonography through the lesion on the left eye. A-scan
measurements show high internal reﬂectivity suggestive of a vascularized lesion. Low
reﬂectivity beneath and surrounding the lesion is consistent with a retinal
detachment.
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A strong VEGF presence, associated with retinal and subretinal
neovascularization, has been found in both neovascularized retinas
of sickle cell patients and in surgically removed VPT.1 6 9 Further-
more, vasoproliferative tumors showed regression with anti-VEGF
therapy in two different reports. 1 3 Given these reports, there
may be biological plausibility that amount of ischemia seen in pa-
tients with SCR may be enough to stimulate the growth of a sec-
ondary VPT through a VEGF mediated pathway.
The ﬁrst association of a VPT with sickle cell disease was made
by Galinos et al. in 1979 where they reported a 52 year old Haitian
man with SC disease who presented with bilateral angioma-like
lesions with overlying ﬁbrous membranes.9 The patient under-
went scleral buckle surgery, external subretinal ﬂuid drainage, and
diathermy to destroy the tumors. Unexpectedly, the patient died six
days following surgery. Histological examination of the eye showed
sickled erythrocytes in the retinal neovascular proliferations within
a matrix of PAS positive material. Pathological reports of VPT from
other causes show signiﬁcant glial cell proliferation along the
vascular tumors.10 Machemer suggested that these ﬁbrous mem-
branes might be the result of leakage of proteinaceous exudate
from abnormal vasculature.11 Alterations in the overlying vitreous
caused by leaking retinal vascular tumors may result in vitreous
separation leading to breaks in the internal limiting membrane
through which glial cells can migrate and proliferate.12 These
membranes can lead to traction of the retina and in some cases lead
to macular epiretinal membrane or peripheral traction detach-
ment.13 McDonald and colleagues reported ten cases of traction
macular detachment in patients with peripheral retinal angioma
and in ﬁve of them, additional signiﬁcant peripheral traction de-
tachments were observed.13 In our case, it is conceivable that with
peripheral traction, nearby atrophic hole formation occurred
leading to the rhegmatogenous component of the detachment.When central vision is threatened by macular edema or serous
detachment, treatment for VPT can be performed using laser
photocoagulation, cryotherapy, or both and may result in tumor
regression.14 More recently, anti-VEGF therapy has been shown to
be helpful as an adjunctive treatment.1,3 Vitrectomy surgery with
speciﬁc attention to ﬁbrous components of VPT is generally
reserved for visually signiﬁcant epiretinal membrane (ERM) for-
mation, vitreous hemorrhage, TRD, RRD, and proliferative vitreor-
etinopathy (PVR) and can lead to good results.13 Tumors can be
treated prior to or during vitrectomy surgery. Pretreatment with
cryotherapy or laser to the tumor in uncomplicated cases (e.g.,
ERM)may be helpful.13 In eyes where signiﬁcant traction is present,
as in cases of TRD or PVR, pretreatment may lead to worsening
traction and should be performed with caution.13 In patients with
sickle cell retinopathy, previous reports suggested that placement
of a scleral buckle can lead to post-operative ocular ischemia;
however, a more recent report have shown this risk to be minimal
and scleral buckling should be considered if deemed beneﬁcial.15
Clinicians should be aware of the possible association of VPT
with SCR. Serum hemoglobin electrophoresis can be helpful in
diagnosing the underlying hematologic condition. Prompt recog-
nition and surgical management of the potential complications
associated with VPT and SCR when appropriate can lead to
improved outcomes.
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